Nicorette Invisi Patch (Nicotine)

Nicorette Invisi Patch is a nicotine replacement therapy used in the management of nicotine dependence.

• Smoking cessation: provides a steady nicotine dose to reduce withdrawal and cravings during quit attempts.
• Tobacco dependence: supports adults who wish to stop smoking by delivering nicotine transdermally.
• Relapse prevention: helps maintain abstinence after initial cessation by mitigating occasional cravings.
• Nicotine withdrawal management: alleviates symptoms such as irritability, anxiety, and concentration difficulties.

• Nicotine delivered through the Invisi Patch is absorbed through the skin into the systemic circulation, where it binds to neuronal nicotinic acetylcholine receptors (nAChRs) in the brain. This activation produces modest dopamine release, mimicking the pharmacologic effects of cigarette smoking and thereby reducing the intensity of withdrawal symptoms and cravings while allowing the smoker to taper nicotine exposure gradually over a period of several weeks.

The most frequently reported reactions to nicotine transdermal patches involve the application site and mild systemic symptoms.

Common Side Effects

• Skin irritation: redness, itching, or rash at the patch site.
• Sleep disturbance: vivid dreams or insomnia.
• Headache: mild to moderate headache.
• Nausea: occasional nausea or stomach discomfort.
• Dizziness: light‑headed feeling, especially when standing quickly.
• Mood changes: irritability or anxiety.
• Mouth irritation: tingling or dryness.

Serious or Rare Side Effects

• Allergic reaction: swelling, hives, or difficulty breathing.
• Cardiovascular events: chest pain, palpitations, or hypertension.
• Severe skin reaction: blistering or necrosis.

When using Nicorette Invisi Patch, several precautions should be observed to ensure safe and effective therapy.

• Assess suitability: confirm the patient is an adult smoker motivated to quit.
• Avoid use with other nicotine products: concurrent use may increase nicotine exposure.
• Monitor cardiovascular status: patients with heart disease should use under medical supervision.
• Discontinue if severe skin reaction occurs: remove patch and seek medical advice.
• Do not apply to damaged or irritated skin: choose a clean, dry area.
• Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Nicotine delivered via the Invisi Patch can interact with certain medicines, altering their effects or increasing adverse risk.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): combined use may heighten hypertensive response.
• Certain antihypertensives (beta‑blockers): nicotine may reduce their blood‑pressure‑lowering efficacy.
• Insulin or oral hypoglycemics: nicotine can affect glucose control, requiring dose adjustment.

Moderate Interactions (Monitor Closely)

• Caffeine‑containing products: nicotine may increase stimulant effects, leading to jitteriness.
• Psychiatric medications (e.g., antipsychotics): nicotine may alter plasma levels, necessitating monitoring.
• Hormonal contraceptives: nicotine may reduce effectiveness, advise alternative methods.